THE KETAMINE BLUE DIARIES

No clinically important variations in the pharmacokinetics of midazolam (CYP3A4 substrate) or its metabolite one-hydroxymidazolam have been noticed when applied concomitantly with single or many doses of lumateperone in people with schizophrenia.Up to now, there was speculation that ketamine masked depression by generating anyone sense “high.”